CERo Therapeutics Holdings, Inc. (CEROW)

USD 0.01

(-23.73%)

Market Cap (In USD)

455.87 Thousand

Revenue (In USD)

-

Net Income (In USD)

-2536.23

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.009-0.0119
PE
-
EPS
-
Beta Value
-0.463
ISIN
US71902K1135
CUSIP
-
CIK
1870404
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Brian G. Atwood
Employee Count
-
Website
https://www.cero.bio
Ipo Date
Details
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.